REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 54 filers reported holding REPLIMUNE GROUP INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,561,736 | -16.4% | 2,370,645 | +13.5% | 0.00% | -33.3% |
| Q2 2023 | $48,506,139 | -5.4% | 2,088,981 | -28.1% | 0.00% | 0.0% |
| Q1 2023 | $51,290,892 | -36.3% | 2,904,354 | -1.8% | 0.00% | +50.0% |
| Q4 2022 | $80,487,194 | +221.0% | 2,959,088 | +103.8% | 0.00% | 0.0% |
| Q3 2022 | $25,072,000 | -13.2% | 1,451,775 | -12.1% | 0.00% | 0.0% |
| Q2 2022 | $28,873,000 | -0.7% | 1,651,754 | -3.5% | 0.00% | +100.0% |
| Q1 2022 | $29,070,000 | -14.4% | 1,712,037 | +36.6% | 0.00% | -50.0% |
| Q4 2021 | $33,973,000 | -28.7% | 1,253,617 | -22.1% | 0.00% | -33.3% |
| Q3 2021 | $47,672,000 | -26.3% | 1,608,377 | -4.5% | 0.00% | 0.0% |
| Q2 2021 | $64,688,000 | +13.0% | 1,683,711 | -10.2% | 0.00% | 0.0% |
| Q1 2021 | $57,232,000 | -4.3% | 1,875,832 | +19.6% | 0.00% | -25.0% |
| Q4 2020 | $59,815,000 | +747.6% | 1,567,887 | +411.4% | 0.00% | – |
| Q3 2020 | $7,057,000 | -0.1% | 306,581 | +7.8% | 0.00% | -100.0% |
| Q2 2020 | $7,067,000 | +232.1% | 284,374 | +33.2% | 0.00% | – |
| Q1 2020 | $2,128,000 | -23.9% | 213,465 | +9.5% | 0.00% | – |
| Q4 2019 | $2,798,000 | +9.6% | 194,981 | +6.1% | 0.00% | – |
| Q3 2019 | $2,553,000 | +0.5% | 183,687 | +6.0% | 0.00% | – |
| Q2 2019 | $2,540,000 | +54.5% | 173,281 | +60.4% | 0.00% | – |
| Q1 2019 | $1,644,000 | +65.4% | 108,017 | +8.7% | 0.00% | – |
| Q4 2018 | $994,000 | -18.3% | 99,381 | +31.7% | 0.00% | – |
| Q3 2018 | $1,216,000 | – | 75,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,050,187 | $53,866,302 | 35.13% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $37,055,978 | 5.02% |
| Redmile Group, LLC | 3,811,988 | $67,319,708 | 2.92% |
| Nan Fung Group Holdings Ltd | 189,339 | $3,343,727 | 2.28% |
| Altium Capital Management LP | 148,000 | $2,613,680 | 1.45% |
| Integral Health Asset Management, LLC | 395,000 | $6,975,700 | 1.40% |
| BVF INC/IL | 2,143,036 | $37,846,016 | 1.38% |
| Resolute Capital Asset Partners LLC | 82,500 | $1,457 | 1.06% |
| SECTORAL ASSET MANAGEMENT INC | 262,200 | $4,630,452 | 0.89% |
| Frazier Life Sciences Management, L.P. | 686,762 | $12,128,217 | 0.88% |